Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme -- Ignore unavailable to you. Want to Upgrade?

To: cool who wrote (3501)	6/9/1998 10:10:00 AM
From: Leman	Read Replies (1) \| Respond to of 8798

Tuesday June 9, 7:30 am Eastern Time Company Press Release Life Medical Sciences Announces Retail Distribution Order For CLINICEL By Genovese Drug Store Chain Includes 132 Stores in New York City and Suburbs EDISON, N.J.--(BW HealthWire)--June 9, 1998--Life Medical Sciences Inc. (Nasdaq NM: CHAI - news) Tuesday announced that it has received an initial stocking order from New York-based Genovese Drug Stores for the company's CLINICEL(TM) silicone gel-filled cushions, which are designed to provide comfortable, topical therapy for problem scars. According to the announcement by Life Medical Sciences President and Chief Executive Officer Robert P. Hickey, Genovese, a 132-store chain servicing New York City and suburban markets, plans to feature CLINICEL in a special pharmacy countertop display in each of its stores. According to a recent trade publication, the emerging scar treatment market is expected to grow to more than $150 million annually during the next five to ten years. CLINICEL scar treatment products, which retail between $60 and $100, are designed to improve the appearance and enhance the comfort of scars from surgery or other skin trauma, including cuts, burns, keloids and cystic acne, by applying the unique silicone gel-filled cushions over the traumatized site. Federal government data indicate that more than 60 million new scars are created each year, including 25 million from surgical procedures. Life Medical Sciences launched CLINICEL in May through an aggressive media campaign targeted at women in such journals as Cosmopolitan, Essence and Redbook. The campaign seeks to create awareness among the millions of people dealing with problem scars of the clinically demonstrated healing achieved with the CLINICEL cushions. Similar ads are directed at medical professionals and retail trade buyers. Hickey commented: ''The results to date from consumers generated by the CLINICEL advertising campaign have been significant, both in terms of the number of callers and sales generated from initial calls. ''Initial consumer calls have resulted in more than 3,000 orders for CLINICEL cushions and ancillary products since the launch one month ago,'' he said, ''and have generated a number of inquiries from retail buyers. The fact that these orders have come by telephone as a direct consumer response to our advertising is encouraging, especially since we are now beginning to augment our marketing campaign by entering retail chain stores. As we continue our aggressive advertising program, we have begun discussions with numerous chain retail outlets nationwide to place the product line into their stores and anticipate additional CLINICEL orders from other chain stores during the next several months. ''In addition to shipping the initial orders,'' Hickey said, ''we have already mailed more than 10,000 CLINICEL information packages as a response to inquiries by consumers, medical professionals and retail buyers. While we are very pleased with the impressive start of the CLINICEL marketing program,'' he continued, ''it is too early to determine the significance of its contribution to the company's bottom line in fiscal 1998. This is primarily due to the moderating effect of associated product launch expenses, ongoing advertising and promotional expenses and uncertainty of the extent of market penetration through the balance of the year.'' The effectiveness of CLINICEL was demonstrated in a clinical study published in the April 1998 edition of the Journal of Plastic and Reconstructive Surgery, the peer review journal for plastic surgeons.